Business Context and Reporting Period
KALA BIO, Inc. (KALA) filed this Form 8-K on November 9, 2025, to disclose the entry into a material definitive agreement and other significant events. The Company is currently facing severe liquidity constraints following actions by its existing lender, Oxford Finance LLC.
Key Financial Metrics and Obligations
- New Convertible Loan: Entered into a Convertible Loan Agreement for up to $375,000 with an individual non-U.S. investor.
- Funding Schedule: $187,500 to be funded by November 10, 2025, and the remaining $187,500 by November 12, 2025.
- Interest Rate: 15% per annum simple interest, payable monthly starting December 2025.
- Maturity: Due one year from the receipt of funds, with an option to extend for one additional year.
- Use of Proceeds: Restricted solely to facilitating a new investment transaction with the Lender and preparing the Form 10-Q for the quarter ended September 30, 2025.
- Existing Debt Status: Oxford Finance LLC previously swept substantially all of the Company's cash resources and intended to foreclose on remaining assets.
Material Changes and Recent Events
On November 3, 2025, Oxford Finance LLC paused its foreclosure proceedings and released $125,000 of previously swept cash to the Company. This release was conditional, intended to fund the negotiation of the new Loan Agreement and preliminary work on the Quarterly Report. Without the successful consummation of the new financing or a strategic transaction, Oxford intends to resume foreclosure efforts.
Outlook, Risks, and Management Commentary
- Strategic Options: The Company plans to explore strategic options including a sale, license, merger, or monetization of assets, contingent on securing additional funding.
- Operational Continuity: Resumption of research and development activities is subject to the availability of additional funding.
- Conversion Rights: The Lender may convert the loan into common stock at specified prices or upon a Liquidity Event (M&A or Public Offering).
- Key Risks: There is no assurance that additional financing or a strategic transaction will be completed. If the Company fails to secure further capital, it faces imminent foreclosure by Oxford Finance LLC.
Investor Verification Checklist
- Confirm the actual receipt of the $375,000 loan proceeds by the specified closing dates (Nov 10 and Nov 12, 2025).
- Monitor the status of the foreclosure proceedings by Oxford Finance LLC and whether they have been permanently stayed.
- Verify the filing of the Form 10-Q for the quarter ended September 30, 2025, which is a condition of the current funding.
- Assess the likelihood of the Company securing the "additional investment transaction" mentioned as a primary use of proceeds.
- Review the specific conversion price terms in the full Loan Agreement exhibit to understand potential dilution.